BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12428091)

  • 1. Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strength.
    Kudaravalli R; Tidd T; Pinotti M; Ratti A; Santacroce R; Margaglione M; Dallapiccola B; Bernardi F; Fortina P; Devoto M; Pollak ES
    Thromb Haemost; 2002 Nov; 88(5):763-7. PubMed ID: 12428091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene.
    Sacchi E; Tagliabue L; Scoglio R; Baroncini C; Coppola R; Bernardi F; Mannucci PM
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):114-7. PubMed ID: 8735799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARP1 interacts with the 5' flanking region of the coagulation factor VII gene.
    Carew JA; Jackson AA; Bauer KA
    J Thromb Haemost; 2003 Jun; 1(6):1220-7. PubMed ID: 12871323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VII polymorphisms in populations with different risks of cardiovascular disease.
    de Maat MP; Green F; de Knijff P; Jespersen J; Kluft C
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1918-23. PubMed ID: 9351354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of the genetic variability in the F7 gene promoter.
    Sabater-Lleal M; Chillón M; Howard TE; Gil E; Almasy L; Blangero J; Fontcuberta J; Soria JM
    Atherosclerosis; 2007 Dec; 195(2):262-8. PubMed ID: 17292373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease.
    Carew JA; Basso F; Miller GJ; Hawe E; Jackson AA; Humphries SE; Bauer KA
    J Thromb Haemost; 2003 Oct; 1(10):2179-85. PubMed ID: 14521602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese.
    Liu Y; Heng CK; Saha N; Hong S; Low PS
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):217-24. PubMed ID: 11943935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.
    van 't Hooft FM; Silveira A; Tornvall P; Iliadou A; Ehrenborg E; Eriksson P; Hamsten A
    Blood; 1999 May; 93(10):3432-41. PubMed ID: 10233895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity.
    Ning B; Nowell S; Sweeney C; Ambrosone CB; Williams S; Miao X; Liang G; Lin D; Stone A; Ratnasinghe DL; Manjanatha M; Lang NP; Kadlubar FF
    Pharmacogenet Genomics; 2005 Jul; 15(7):465-73. PubMed ID: 15970794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphism in the 5' region of coagulation factor VII gene (F7) caused by an inserted decanucleotide.
    Marchetti G; Patracchini P; Papacchini M; Ferrati M; Bernardi F
    Hum Genet; 1993 Jan; 90(5):575-6. PubMed ID: 8381388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Haplotype Analysis of Coagulation Factor VII Gene in a Patient with Congenital Coagulation Factor VII Deficiency with Heterozygous p.Arg337Cys Mutation and o.Aro413Gin Polymorphism..].
    Suzuki K; Yoshioka T; Obara T; Suwabe A
    Rinsho Byori; 2016 May; 64(4):380-386. PubMed ID: 29182802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No significant association between the promoter region polymorphisms of factor VII gene and risk of venous thrombosis in cancer patients.
    Eroğlu A; Oztürk A; Cam R; Akar N
    Exp Oncol; 2010 Mar; 32(1):15-8. PubMed ID: 20332763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
    Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
    Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency.
    Zheng XW; Kudaravalli R; Russell TT; DiMichele DM; Gibb C; Russell JE; Margaritis P; Pollak ES
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):624-7. PubMed ID: 21760481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic contribution to variable human CYP3A-mediated metabolism.
    Lamba JK; Lin YS; Schuetz EG; Thummel KE
    Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis.
    Bozzini C; Girelli D; Bernardi F; Ferraresi P; Olivieri O; Pinotti M; Martinelli N; Manzato F; Friso S; Villa G; Pizzolo F; Beltrame F; Corrocher R
    Thromb Haemost; 2004 Sep; 92(3):541-9. PubMed ID: 15351850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies.
    Hunault M; Arbini AA; Lopaciuk S; Carew JA; Bauer KA
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2825-9. PubMed ID: 9409261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism (Arg353-->Gln) in coagulation factor VII gene and factor VII levels (coagulant activity, antigen and binding ability to tissue factor) in 101 healthy Japanese.
    Takamiya O
    Scand J Clin Lab Invest; 1995 May; 55(3):211-5. PubMed ID: 7638554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.
    Pitarque M; von Richter O; Rodríguez-Antona C; Wang J; Oscarson M; Ingelman-Sundberg M
    Hum Mutat; 2004 Mar; 23(3):258-66. PubMed ID: 14974084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic search for single nucleotide polymorphisms in the 5' flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes.
    Osawa H; Niiya T; Onuma H; Murakami A; Ochi M; Nishimiya T; Ogura T; Kato K; Shimizu I; Fujii Y; Ohashi J; Yamada K; Liang SJ; Manganiello VC; Fujita-Yamaguchi Y; Makino H
    Mol Genet Metab; 2003 May; 79(1):43-51. PubMed ID: 12765845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.